PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

Fierce Pharma

healthCenter

1d ago

<a href="https://www.fiercepharma.com/pharma/fda-docs-reveal-lingering-concerns-intervention-behind-replimunes-long-sought-melanoma-nod" hreflang="en">FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod</a>translating…

Two votes of confidence from leaders at the FDA’s Office of Clinical Evaluation and the Oncology Center of Excellence sealed Replimune’s fate, overruling review staffers’ concerns and paving the way for last month’s accelerated nod for Tudriqev.

Factuality

76/100

Political Bias

Center

Ownership

Questex

Country

USA

Region

North America

Language

English

Keywords#Replimune#concerns#nod#health

Read Original ↗ Article view

Comments

Loading comments…

<a href="https://www.fiercepharma.com/pharma/fda-docs-reveal-lingering-concerns-intervention-behind-replimunes-long-sought-melanoma-nod" hreflang="en">FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod</a> | Pulse Aggregator